NASDAQ: MEDPMedpace Holdings Inc Stock
$387.14-7.86 (-1.99%)
Updated Apr 15, 2024
MEDP Price
$387.14
Fair Value Price
$388.37
Market Cap
$11.91B
52 Week Low
$185.43
52 Week High
$419.42
P/E
42.08x
P/B
21.3x
P/S
4.99x
PEG
12.03x
Dividend Yield
N/A
Revenue
$1.89B
Earnings
$282.81M
Gross Margin
27.8%
Operating Margin
17.83%
Profit Margin
15%
Debt to Equity
1.96
Operating Cash Flow
$433M
Beta
1.23
Next Earnings
Apr 23, 2024
Ex-Dividend
N/A
Next Dividend
N/A
MEDP Overview
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MEDP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MEDP ($387.14) is undervalued by 0.32% relative to our estimate of its Fair Value price of $388.37 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MEDP ($387.14) is not significantly undervalued (0.32%) relative to our estimate of its Fair Value price of $388.37 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
MEDP ($387.14) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MEDP due diligence checks available for Premium users.
Be the first to know about important MEDP news, forecast changes, insider trades & much more!
MEDP News
Valuation
MEDP fair value
Fair Value of MEDP stock based on Discounted Cash Flow (DCF)
Price
$387.14
Fair Value
$388.37
Undervalued by
0.32%
MEDP ($387.14) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MEDP ($387.14) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MEDP ($387.14) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
MEDP price to earnings (PE)
For valuing profitable companies with steady earnings
Company
42.08x
Industry
36.95x
Market
41.94x
MEDP is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MEDP is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
MEDP price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
21.3x
Industry
4.12x
MEDP is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MEDP price to earnings growth (PEG)
For valuing profitable companies with growth potential
MEDP is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
MEDP's financial health
Profit margin
Revenue
$498.4M
Net Income
$78.3M
Profit Margin
15.7%
MEDP's Earnings (EBIT) of $336.17M... subscribe to Premium to read more.
Interest Coverage Financials
MEDP's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.7B
Liabilities
$1.1B
Debt to equity
1.96
MEDP's short-term liabilities ($925.13M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MEDP's short-term assets ($593.83M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MEDP's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MEDP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$156.4M
Investing
-$8.0M
Financing
$1.5M
MEDP's operating cash flow ($433.37M)... subscribe to Premium to read more.
Debt Coverage Financials
MEDP vs Diagnostic & Research Stocks
Medpace Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.